Glenmark Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Glenmark Pharma Quarterly Results    (GLPH)

Here are the latest quarterly results of Glenmark Pharma. For more details, see the Glenmark Pharma financial fact sheet and Glenmark Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Glenmark Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m21,65625,81325,55025,63523,22928,15027,35627,675 
Other income Rs m1,3821,399-1,09039117808330441 
Turnover Rs m23,03827,21224,46026,02523,24528,95927,68528,116 
Expenses Rs m18,18721,41221,20421,99319,81023,64622,95523,018 
Gross profit Rs m3,4696,0734,3473,6413,4194,5044,4014,986 
Depreciation Rs m7948258318109079421,0601,263 
Interest Rs m790851885819930898961985 
Profit before tax Rs m3,2675,7961,5402,4031,5983,4732,7103,180 
Tax Rs m9371,656377786506918801977 
Profit after tax Rs m2,3304,1401,1631,6171,0932,5551,9082,203 
Gross profit margin %16.023.517.014.214.716.016.118.0 
Effective tax rate %28.728.624.532.731.626.429.630.7 
Net profit margin %10.816.04.66.34.79.17.08.0 
Diluted EPS Rs 8.3 14.7 4.1 5.7 3.9 9.1 6.8 7.8  
Diluted EPS (TTM) Rs 24.9 32.0 32.4 32.8 28.4 22.8 25.4 27.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Glenmark Pharma 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   PIRAMAL ENTERPRISES  NOVARTIS  FRESENIUS KABI ONCO.  SUN PHARMA  NATCO PHARMA  

Compare GLENMARK PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  FRESENIUS KABI ONCO.  SUN PHARMA  NATCO PHARMA  

Compare GLENMARK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Crashes 667 Points; Banking and Finance Stocks Bleed(Closing)

Indian share markets extended losses as the session progressed and ended their day deep in the red, amid a huge selloff in banking and financial services stocks.

Views on news

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GLENMARK PHARMA has posted a net profit of Rs 1 bn (down 53.1% YoY). Sales on the other hand came in at Rs 23 bn (up 7.3% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

More Views on News

Most Popular

Why the Stock of HDFC Bank Deserves a Closer Look than Before... (Profit Hunter)

Jul 22, 2020

HDFC Bank's results point to a gaping hole in Indian financial sector. Possibly even a global contagion.

My Best Trading Ideas When Interest Rates Are So Low (Fast Profits Daily)

Jul 23, 2020

India's interest rates are lower than the inflation rate. Here are the best trades for this situation.

The Smallcap Stock that Made Me Change My Asset Allocation Rule (Profit Hunter)

Jul 21, 2020

I believe this smallcap niche leader could deliver a non-linear payoff.

Gold or Silver: Which One Should You Buy Now? (Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Aug 3, 2020 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - SUN PHARMA COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS